Summary:
Rana Foroohar on what the effect will be of $200 oil on the global economy. No industry will be unaffected. Long-term demand will continue to grow while supply threats aren't going to go away rightaway. $200 in 6 to 24 months (Goldman Sachs estimate) is to fast for economies to cope. China and India have kept inflation down with cheap goods, but will be exporters of inflation once energy subsidies are reduced or stopped: end of cheap goods. Shift toward regional trade (regionalism), even major reversal of globalization itself, due to rising transport costs. Increase in corporate failures, and a lot of M&A; emerging-market firms swooping up ailing Western firms on the cheap. Effects will be worse for poor people in developing economies. Number of oil states rising as prices climb, ill-equiped to cope with corruption that oil-wealth brings. Shift in balance of world power, conflicts increasing. (Published: 31/05/08)
Notes:
Saturday, May 31, 2008
The Coming Energy Wars - Newsweek
Friday, May 30, 2008
Global CEO Study, 2008 - IBM
Summary:
IBM study on thoughts and views on the future of business (the "Enterprise of the Future"). Concludes that the Enterprise of the Future hungry for change, innovative beyond customer imagination, globally integrated, disruptive by nature and genuine, not just generous. CEOs are most concerned about the impact of three external forces: market factors, people skills and technology. Organisation should act like VCs to establishe processes and structures that promote innovation and transformation. Informed and collaborative customers are viewed as chance to differentiate. Views of globalization are shifting from labor arbitrage and riding the wave of economic growth in China and India to global integration. Majority sees M&A as part of their global integration strategies. Business model innovation more important because it is increasingly difficult to differentiate based on products and services alone. CSR increasingly important, impacting on both top and bottom lines. (Published: 30/05/08)
Notes:Change
Innovation
timing.Global integration
Disruptiveness
Corporate Social Responsibility
Tuesday, May 20, 2008
Preserving the open economy at times of stress - FT.com
Summary:
Martin Wolf on benefits and perils for the West of rising global prosperity. Major disadvantage is competition for scarce resources. However, it is a trend that is unstoppable, and West needs to embrace it rather than oppose it. The question is: how much openness to trade and movement of capital and labour should there be? Large minority of people in US believe free-trade policies are not in their interest. US needs to shift provision of security from employers to the state: corporate welfare states are unsustainable in a dynamic and open economy. Solution according to Wolf is raise taxation of the rich so as to distribute the spoils of globalisation more evenly. Wolf does not agree with Summers' argument for international action against tax competition and increased international agreement on regulation. Globalisation being used as an excuse for low taxes. (Published: 20/05/08)
Notes:
Sunday, May 18, 2008
The Chinese Brand of Democracy - The Globalist
Summary:
Chinese intellectuals question need for democracy in China. Demythologizing democracy and separating it from rule of law. Prosperity and growth not result of democracy, but of rule of law. West can enjoy both because of level of modernity and material wealth. Developing countries need to chose one. Choosing democracy first leads to chaos (e.g. Rwanda, Yugoslavia). Need to chose rule of law above democracy. (Published: 16/05/2008)
Notes:
Saturday, May 17, 2008
A strategy to promote healthy globalisation - FT.com
Summary:
Second part of Larry Summers' on rising anti-free trade sentiment and strategies to avoid it. Increasingly succesful and integrated global economy at the expense of US workers? Difference between open and closed economy (reasoning similar to that of Gomory and Baumont). US must compete not retreat. Current emphasis on priority of global corporations. Need to focus on interests of working people, too. Need global co-operation in international tax arena and prevention of harmful de-regulation eroding labour rights. (Published: 14/05/2008)
Notes:
Thursday, May 15, 2008
Getting the right picture - Pittsburgh Tribune-Review
Summary:
Don Boudreaux on how some may see more imports from abroad and domestic job losses as a sign of trouble, and others see them as a boon, depending on one's perspective. Same facts, different interpretation. Compare with drawing of old woman/beautiful girl. One and the same picture, but depending ond your perspective, you see either the former or the latter. (Published: 14/05/2008)
Notes:
Tuesday, May 13, 2008
The oily truth about America’s foreign policy - FT.com
Summary:
Gideon Rachman editorial in the FT. American presidents and candidates have been pledging energy independence from Middle-Eastern oil since Nixon (first oil crisis). In reality dependence has increased. Competition for oil increasing. Biggest challenged posed by globalisation not outsourcing of jobs or influx of cheap goods, but globalisation of Western consumption patterns. If Chinese and Indians eventually drive and eat as Europeans and Americans, current oil and food crisis is just the beginning. New technology and change in lifestyle will be required. (published: 13/05/2008)
Notes:
Sunday, May 11, 2008
Why oil is so expensive - De Standaard (in Dutch)
Summary:
Three years ago, when oil reached $50, economist's were already saying that price was too high. Today, oil costs two-and-a-half times as much. An analysis of what has happened. Factors considered are: inflation, dollar exchange rate, institutional investors, supply and demand, OPEC, refining capacity, alternatives. (published: 10/05/2008)
Notes:
Thursday, May 8, 2008
Battling Bad Bugs - Drug Discovery & Development
Summary:
Microbes are evolving resistance faster than the pharmaceutical industry can bring new products to market. Microbes have been persistently clever in evolving resistance to antibiotics soon after introduction. Emergence of "Bad Bugs, No Drugs" situation; high economic burden and will gradually worsen. Call to action from the infectious disease community (IDSA). A new type of product specialization is required (relying on rapid molecular diagnostic tests), but this runs counter to the blockbuster model of large pharmaceutical companies. Opportunity for smaller companies. US government under pressure to create incentives for the large pharmaceutical companies to remain in antibiotic discovery. Some incentives in the FDAAA act, but disincentives remain. (Published: 08/05/08)
Notes:
Tuesday, May 6, 2008
Going Green: A Wealth of Job Openings - FT.com
Summary:
Environment has become a strategic issue for oil and gas companies in recent years, not just PR. Looking for sustainability experts. Fast growth of the alternative energy sector (investment in 2007 up 60% over 2006) means shortages, not just components and equipment, but also human capital. Strain on the availability of senior managers with sector experience (CTOs, CEOs and senior project managers). Need technical skills, commercial awareness and understanding of business, and communications skills. For senior managers with positions reporting to the board, the rewards can be high. (Published: 06/05/08)
Notes:
Monday, May 5, 2008
Quote of the Day
"The crossroads of trade are the meeting place of ideas, the attrition ground of rival customs and beliefs; diversities beget conflict, comparison, thought; superstitions cancel one another, and reason begins." - Will Durant
Thursday, May 1, 2008
Super Drugs for Super Bugs - Drug Discovery & Development
Summary:
Antimicrobial resistance is a monumental health problem, affecting everyone from infected patients and physicians to researchers and drug developers. E.g. evolution from S. aureus to MRSA, hospital acquired versus community acquired. Dangers of SCCmec. Many antimicrobials coming out for resistant Gram-positive bacteria like MRSA, but there is nothing for Gram-negative bacteria. Increased research effort toward understanding mechanisms of resistance, as well as identifying new antimicrobial targets, is greatly needed. Large drug companies are well aware of the problem, but have been fighting an uphill battle to develop antibiotics that exist long enough on the market to profit. Smaller drug companies and academic institutions have taken it upon themselves to develop new antimicrobials. These drug developers require large drug companies to put their discoveries on the market. (Published: 01/05/08)
Notes: